The effect of synthetic gestagens on progesterone formation in vitro in human corpus luteum of early pregnancy.
D000500:Allylestrenol / Q000494:pharmacology; D003338:Corpus Luteum / Q000378:metabolism*; D004394:Dydrogesterone / Q000494:pharmacology; D004963:Estrenes / Q000494:pharmacology; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008234:Lynestrenol / Q000494:pharmacology; D008525:Medroxyprogesterone / Q000494:pharmacology; D008535:Megestrol / Q000494:pharmacology; D009640:Norethindrone / Q000494:pharmacology; D009641:Norethynodrel / Q000494:pharmacology; D009644:Norgestrel / Q000494:pharmacology; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011374:Progesterone / Q000096:biosynthesis*; D045167:Progesterone Congeners / Q000494:pharmacology*
D004963:Estrenes; D045167:Progesterone Congeners; D009644:Norgestrel; D011374:Progesterone; D009641:Norethynodrel; D004394:Dydrogesterone; D008535:Megestrol; D008525:Medroxyprogesterone; D000500:Allylestrenol; D008234:Lynestrenol; D009640:Norethindrone